| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 20, 2013 | Alpha Street Research | Hunter Orr | MRK - Merck & Co Inc - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (MRK). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 17, 2013 | Reuters Investment Profile | N/A | Merck & Co Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | May 16, 2013 | New Constructs, LLC | N/A | MRK: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 16, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - MERCK & CO. , INC. (MRK-N) | 12 | $25 | | May 16, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Large CAP Pharma | 17 | $195.50 | | May 16, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MERCK & CO including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 16, 2013 | S&P Capital IQ – STARS Reports | N/A | Merck & Co | 10 | $115 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for MRK | 11 | $126.50 |
|
View All Reports for MRK ... |
|
|
0.38(0.82%) May 17, 4:00PM EDT|After Hours
:
45.99 0.00 (0.00%) May 17, 6:28PM EDT